CORMEDIX INC. (CRMD) Operating cash flow 2016–2025
CORMEDIX INC. (CRMD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$175.0MFY2025 · since FY2016: -$22.3M → $175.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $175.0M | +445.8% |
| FY2024 | -$50.6M | -31.8% |
| FY2023 | -$38.4M | -57.7% |
| FY2022 | -$24.4M | -15.1% |
| FY2021 | -$21.2M | +3.7% |
| FY2020 | -$22.0M | -45.9% |
| FY2019 | -$15.1M | +36.5% |
| FY2018 | -$23.7M | +17.1% |
| FY2017 | -$28.6M | -28.4% |
| FY2016 | -$22.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CRMD financial trends
CRMD RevenueCRMD Net incomeCRMD Net marginCRMD Gross profitCRMD Gross marginCRMD Operating incomeCRMD Operating marginCRMD Free cash flowCRMD Capital expendituresCRMD Return on equityCRMD Stock buybacksCRMD Dividends paidCRMD Total assetsCRMD Total liabilitiesCRMD Shareholders’ equityCRMD overview →